CY1113621T1 - Χρηση ειδικων ιστονων για τη θεραπευτικη αντιμετωπιση παρασιτικων νοσων - Google Patents
Χρηση ειδικων ιστονων για τη θεραπευτικη αντιμετωπιση παρασιτικων νοσωνInfo
- Publication number
- CY1113621T1 CY1113621T1 CY20121101167T CY121101167T CY1113621T1 CY 1113621 T1 CY1113621 T1 CY 1113621T1 CY 20121101167 T CY20121101167 T CY 20121101167T CY 121101167 T CY121101167 T CY 121101167T CY 1113621 T1 CY1113621 T1 CY 1113621T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- parasitic diseases
- special patterns
- histone
- histones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση αφορά στη χρήση μιας από τις πρωτεΐνες ιστονών Η2Α, Η2Β, Η3 και Η4 για τη θεραπευτική αντιμετώπιση, διάγνωση ή πρόληψη μιας παρασιτικής νόσου. Κατά προτίμηση, χρησιμοποιούνται και οι τέσσερεις ιστόνες σε συνδυασμό. Εάν χρησιμοποιηθεί μόνο μια ιστόνη, χρησιμοποιείται κατά προτίμηση η ιστόνη Η4. Το μεγάλο πλεονέκτημα της παρούσας εφεύρεσης είναι ότι η παρασιτική νόσος που προκαλείται από ένα είδος δύναται να αντιμετωπιστεί θεραπευτικά με τη χρήση ιστονών από ένα άλλο είδος.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0312421 | 2003-11-05 | ||
EP04799038A EP1687023B1 (en) | 2003-11-05 | 2004-11-04 | Use of specific histones for the treatment of parasitic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113621T1 true CY1113621T1 (el) | 2016-06-22 |
Family
ID=34957005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121101167T CY1113621T1 (el) | 2003-11-05 | 2012-11-29 | Χρηση ειδικων ιστονων για τη θεραπευτικη αντιμετωπιση παρασιτικων νοσων |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1687023B1 (el) |
JP (2) | JP2007514653A (el) |
CN (1) | CN101052413B (el) |
AU (1) | AU2004287284B2 (el) |
BR (1) | BRPI0416246B8 (el) |
CY (1) | CY1113621T1 (el) |
ES (1) | ES2395923T3 (el) |
IL (1) | IL175412A (el) |
PT (1) | PT1687023E (el) |
RS (1) | RS52507B (el) |
RU (1) | RU2380710C2 (el) |
WO (1) | WO2005044301A2 (el) |
ZA (1) | ZA200604053B (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4669687B2 (ja) * | 2004-09-27 | 2011-04-13 | 東芝キヤリア株式会社 | マイクロコンピュータのデータ記憶方法 |
FR2883185B1 (fr) * | 2005-03-18 | 2010-11-26 | Pasteur Institut | Composition comprenant la region n-terminale d'histone h2b de leishmania-utilisation pour induire une reponse immunitaire |
WO2011006891A1 (en) | 2009-07-13 | 2011-01-20 | Laboratorios Leti, S.L. | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
CA2817421C (en) | 2010-11-10 | 2020-04-14 | Laboratorios Leti, S.L. | Adjuvant derived from leishmania species |
CN104717976A (zh) * | 2012-08-30 | 2015-06-17 | 梅里亚有限公司 | 嵌合ksac蛋白的表达和由高压产生可溶性蛋白的方法 |
CN107540735B (zh) * | 2017-10-12 | 2021-11-23 | 中国科学院水生生物研究所 | 一种抗菌蛋白及分离的核酸、抗菌药物和应用 |
EP4348265A2 (en) * | 2021-05-25 | 2024-04-10 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Diagnosis of autism spectrum disorder by multiomics platform |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TNSN97045A1 (fr) * | 1996-03-12 | 2005-03-15 | Sovarec Sa | Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation. |
US6525186B2 (en) * | 1998-12-23 | 2003-02-25 | C.B.F. Leti S.A. | Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained |
-
2004
- 2004-11-04 RU RU2006119462/13A patent/RU2380710C2/ru active
- 2004-11-04 ES ES04799038T patent/ES2395923T3/es active Active
- 2004-11-04 EP EP04799038A patent/EP1687023B1/en active Active
- 2004-11-04 WO PCT/IB2004/004078 patent/WO2005044301A2/en active Application Filing
- 2004-11-04 BR BRPI0416246A patent/BRPI0416246B8/pt active IP Right Grant
- 2004-11-04 RS RS20120469A patent/RS52507B/en unknown
- 2004-11-04 PT PT47990387T patent/PT1687023E/pt unknown
- 2004-11-04 AU AU2004287284A patent/AU2004287284B2/en active Active
- 2004-11-04 JP JP2006538999A patent/JP2007514653A/ja not_active Withdrawn
- 2004-11-04 CN CN200480039820.6A patent/CN101052413B/zh active Active
-
2006
- 2006-05-04 IL IL175412A patent/IL175412A/en active IP Right Grant
- 2006-05-19 ZA ZA2006/04053A patent/ZA200604053B/en unknown
-
2011
- 2011-08-22 JP JP2011180791A patent/JP5623995B2/ja active Active
-
2012
- 2012-11-29 CY CY20121101167T patent/CY1113621T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0416246B8 (pt) | 2021-05-25 |
EP1687023B1 (en) | 2012-10-03 |
IL175412A0 (en) | 2006-09-05 |
JP5623995B2 (ja) | 2014-11-12 |
WO2005044301A3 (en) | 2005-06-30 |
EP1687023A2 (en) | 2006-08-09 |
AU2004287284A1 (en) | 2005-05-19 |
RS52507B (en) | 2013-04-30 |
CN101052413A (zh) | 2007-10-10 |
BRPI0416246B1 (pt) | 2019-01-15 |
RU2006119462A (ru) | 2007-12-20 |
PT1687023E (pt) | 2013-01-23 |
JP2012051886A (ja) | 2012-03-15 |
BRPI0416246A (pt) | 2007-01-09 |
CN101052413B (zh) | 2014-05-14 |
ZA200604053B (en) | 2008-04-30 |
RU2380710C2 (ru) | 2010-01-27 |
JP2007514653A (ja) | 2007-06-07 |
IL175412A (en) | 2012-02-29 |
WO2005044301A2 (en) | 2005-05-19 |
AU2004287284B2 (en) | 2009-11-12 |
ES2395923T3 (es) | 2013-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113621T1 (el) | Χρηση ειδικων ιστονων για τη θεραπευτικη αντιμετωπιση παρασιτικων νοσων | |
CY1110954T1 (el) | Ημιστερεες βλεννοκολλωδεις φαρμακοτεχνικες μορφες | |
CY1114397T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν βακτηρια τα οποια μειωνουν οξαλικα | |
CY1119751T1 (el) | Υλικα και μεθοδοι για θεραπεια ή προληψη ασθενειων που σχετιζονται me her-3 | |
CY1113190T1 (el) | Μεθοδος αγωγης της αιμολυτικης νοσου | |
ATE419865T1 (de) | Verwendung von protein-kinase-n-beta | |
CY1115012T1 (el) | Μεθοδος συστηματικης εξετασης παρασκευασματων παρασιτου για αποτελεσματικοτητα στην αποτροπη και ελεγχο ασθενειων | |
EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
CY1121057T1 (el) | Συμπυκνωμα ελαιωδους εναιωρηματος | |
EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
ATE484201T1 (de) | Verwendung von beta-cryptoxanthin | |
EA202191133A1 (ru) | Сигнатуры интерферона типа i и способы их применения | |
CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
ATE545658T1 (de) | Verfahren zur behandlung von synovialsarkom | |
CY1106092T1 (el) | Χρηση του μακρου μοριου της πεντραξινης ρτχ3 για τη θepαπεια ασθενειων που προκαλουνται απο μια μεταβαλλομενη ενepγοποιηση του αυξητικου παραγοντα fgf-2 | |
ATE417616T1 (de) | Behandlung von mukositis | |
CO2020016480A2 (es) | Sales tópicas de amlodipino para el tratamiento de enfermedades anorrectales | |
ATE376419T1 (de) | Carbostyril-derivate mit selektiven serotonin- aufnahme inhibitoren, zur behandlung von gemütskrankheiten | |
DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
ATE493432T1 (de) | Gewinnung von hitzeschockproteinen | |
CY1105403T1 (el) | Χρηση της ακετυλο-l-καρνιτινης σε συνδυασμο με τη βιοτινη για τη θepαπεια ασθενων με ινσουλινο-ανθεκτικο σακχαρωδη διαβητη τυπου 2 | |
ECSP034743A (es) | Peptidos a partir del anticuerpo 16/61d para tratar lupus eritematoso sistemico | |
ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
ATE332703T1 (de) | Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung | |
ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen |